Hallengren B, Forsgren A, Melander A
J Clin Endocrinol Metab. 1980 Aug;51(2):298-301. doi: 10.1210/jcem-51-2-298.
The in vitro influence of 6-propylthiouracil (PTU) and methimazole (MMi) on mitogenic activation of human peripheral blood lymphocytes was studied in order to assess whether antithyroid drugs may have an immunomodulatory capacity. Lymphocytes were cultured for 72 h in the presence of phytohaemagglutinin (PHA; 1.25 microgram/ml), concanavalin A (Con A; 5.0 microgram/ml), or pokeweed mitogen (PWM; 2.5 microgram/ml). Antithyroid drugs were added to yield final concentrations of 1-1000 mu mol/liter. High pressure liquid chromatographic analyses verified that the expected drug concentrations in the incubation media were reached and maintained throughout the incubation period. The degree of lymphocyte activation was assessed by measurements of the cellular uptake of [3H]thymidine added after 48 h. PTU (at 1000 mu mol/liter) slightly suppressed PHA- and Con A-induced activation of lymphocytes but enhanced (at 5-500 mu mol/liter) PWM-induced activation. MMI (500-1000 mu mol/liter) enhanced not only PWM-induced activation but (at 1000 mu mol/liter) also enhanced PHA- and Con A-induced activation. Thus, PTU and MMI might interfere with mitogenic activation of lymphocytes. However, the effects were mainly recorded at drug concentrations exceeding those found in blood samples of patients treated with conventional doses.
为了评估抗甲状腺药物是否具有免疫调节能力,研究了6-丙基硫氧嘧啶(PTU)和甲巯咪唑(MMi)对人外周血淋巴细胞有丝分裂激活的体外影响。淋巴细胞在植物血凝素(PHA;1.25微克/毫升)、刀豆球蛋白A(Con A;5.0微克/毫升)或商陆有丝分裂原(PWM;2.5微克/毫升)存在的情况下培养72小时。加入抗甲状腺药物以使最终浓度达到1 - 1000微摩尔/升。高压液相色谱分析证实,在整个孵育期间,孵育培养基中达到并维持了预期的药物浓度。通过测量48小时后添加的[3H]胸腺嘧啶核苷的细胞摄取来评估淋巴细胞激活程度。PTU(1000微摩尔/升)轻微抑制PHA和Con A诱导的淋巴细胞激活,但(5 - 500微摩尔/升)增强PWM诱导的激活。MMI(500 - 1000微摩尔/升)不仅增强PWM诱导的激活,而且(1000微摩尔/升)还增强PHA和Con A诱导的激活。因此,PTU和MMI可能会干扰淋巴细胞的有丝分裂激活。然而,这些效应主要是在药物浓度超过常规剂量治疗患者血样中发现的浓度时记录到的。